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General experimental procedures
NMR spectra were recorded in CDCl 3 on a Bruker Avance DRX 500 spectrometer at 500 MHz ( 1 H) or 125 MHz ( 13 C); the signals of the deuterated solvent were taken as a reference. 2D NMR data were acquired and processed with standard Bruker software. Mass spectrometric measurements were performed on a Finnigan TSQ 7000 tandem mass spectrometer (Finnigan MAT) equipped with a Finnigan electrospray ion source. A voltage of 4.5 kV was used in the ion source. The instrument was scanned in the normal MS mode over the mass range 10-1500, with a scan time of 2 s. UV spectra were obtained from the PDA-HPLC investigations. Silica gel plates were applied for analytical TLC (Merck 5554). The chromatograms were visualised at 254 and 366 nm, and by spraying with concentrated H 2 SO 4 , followed by heating at 110°C. For vacuum liquid chromatography (VLC), SiO 2 (silica gel 60GF 254 , 15 µm; Merck 11677) was applied. Rotation planar chromatography (RPC) was performed with a Chromatotron instrument (model 8924; Harrison Research) on manually coated SiO 2 (silica gel 60 GF 254 , Merck 7730; RPC I-VI and RPC VIII-XI) or Al 2 O 3 (aluminium oxide G, type E, Merck 1090; RPC VII) plates 1, 2, or 4 mm thick, at a flow rate of 3, 4, or 10 mL/ min, respectively. Preparative layer chromatography (PLC) was carried out on SiO 2 plates (20 × 20 cm, silica gel 60F 254 ; Merck 5715). Separation was monitored by spraying the border of the plates with concentrated H 2 SO 4 . Reversed-phase HPLC was carried out on a Waters 600 instrument equipped with a LiChrospher 100 RP-18 (10 µm, 250 × 4 mm; Merck) column and a Waters 2998 photodiode array detector. A mobile phase containing MeOH-H 2 O 3 : 2 was applied at a flow rate of 0.4 mL/min; the separation was monitored at 220 nm. 
Plant material
The roots of C. canadensis (L.) Cronq. were collected in the Southern Great Plain (Hungary) 
Extraction and isolation
The air-dried and ground roots of the plant (2.6 kg) were percolated with MeOH (50 L) at room temperature. The concentrated extract (300 mL) was diluted with 300 mL H 2 O and subjected to solvent-solvent partition, first with n-hexane (5 × 2 L) and then with CHCl 3 (7 × 2 L). After evaporation, the n-hexane-soluble phase (16.0 g) was fractionated by VLC (8.5 × 14 cm), using mixtures of n-hexane and EtOAc with increasing polarity [volumetric ratios of 98 : 2, 96 : 4, 94 : 6, 92 : 8, 9 : 1, 8 : 2, 6 : 4, 3 : 7, and 0 : 1 (1120 mL, 800 mL, 640 mL, 2000 mL, 1200 mL, 720 mL, 480 mL, 480 mL, and 800 mL, respectively)]. A total of 103 fractions with a volume of 80 mL each were collected and combined with regard to the results of TLC monitoring, yielding twelve main fractions (A/I-XII). From the marginally active fraction A/III, eluted with n-hexane-EtOAc 94 : 6, friedeline (7) was crystallised (71.5 mg, white crystals, m. p. 257-260°C). Fractions A/IV, A/V, A/VI, A/VII, and A/VIII were found to exert pronounced antiproliferative activity and were analysed in detail. Fraction A/IV (eluted with nhexane-EtOAc 92 : 8), which displayed cell growth-inhibitory effects of 37.1 % (HeLa), 77.2 % (MCF-7), and 63.2 % (A-431), was chromatographed by RPC on silica gel in two steps, first with a gradient system of n-hexane-acetone (RPC I). Subfractions eluted with n-hexane-acetone 19 : 1 from RPC I were next purified by RPC (RPC II) with cyclohexane-EtOAc 9 : 1 as a developing system, affording compound 4 (5.8 mg). Fraction A/IV also contained compound 3, isolated later from the active fraction A/VII. From fraction A/V [eluent: n-hexane-EtOAc 92 : 8; cell proliferation inhibition: 52.9 % (HeLa), 38.8 % (MCF-7), and 49.7 % (A431)], pure epifriedelanol (6) was obtained as white crystals (187.0 mg, m. p. 291-292°C). From the mother liquor of this substance, simiarenol (9) (12.0 mg, white crystals, m. p. 203-205°C) was isolated by means of RPC (RPC III), with a solvent system of n-hexane-acetone 9 : 1 as the mobile phase. Fraction A/VI [eluent: nhexane-EtOAc 92 : 8; cell proliferation inhibition: 55.5 % (HeLa), 65.7 % (MCF-7), and 56.1 % (A-431)] was also subjected to RPC (RPC IV), with a solvent system of toluene-CH 2 Cl 2 1 : 1, which resulted in the isolation of taraxerol (8) (11.1 mg, white crystals, m. p. 283-285°C). In the prominently active fraction A/VII [eluent: n-hexane-EtOAc 9 : 1; cell proliferation inhibition: 87.3 % (HeLa), 85.5 % (MCF-7), and 84.6 % (A-431)], compound 4, isolated from fraction A/IV, was identified as a minor constituent. To obtain the main component, VLC (6 × 6 cm) was applied, with mixtures of n-hexane-acetone of increasing polarity as eluents [96 : 4, 94 : 6, 92 : 8, 9 : 1, and 7 : 3 (280 mL, 370 mL, 440 mL, 390 mL, and 520 mL, respectively); volume of collected fractions: 10 mL each]. The subfractions eluted with n-hexane-acetone 92 : 8 in this separation were purified by RPC (RPC V), with petroleum ether-CH 2 Cl 2 1 : 1 as a solvent system, which yielded compound 3 (139.2 mg). For the separation of fraction A/VIII [eluent: n-hexane-EtOAc 8 : 2; cell proliferation inhibition: 55.9 % (HeLa), 55.4 % (MCF-7), and 52.4 % (A-431)], a subsequent RPC was carried out (RPC VI), with the application of gradient elution (n-hexane-EtOAc). From the subfractions eluted with n-hexane-EtOAc 7 : 3, a crystalline material was obtained (24.5 mg), which was identified as a mixture of β-sitosterol and stigmasterol. From the subfractions eluted with n-hexane-EtOAc 6 : 4, another substance was crystallised, which was further purified by preparative TLC on silica gel (developing system: n-hexane-EtOAc 13 : 5); this afforded spinasterol (10) (9.8 mg, white crystals, m. p. 254-257°C). The CHCl 3 -soluble phase of the extract (20.4 g) was chromatographed via VLC (8.5 × 14.5 cm), using a gradient system of CH 2 Cl 2 -MeOH [98 : 2, 96 : 4, 94 : 6, 9 : 1, and 8 : 2 (800 mL, 900 mL, 1400 mL, 600 mL, and 500 mL, respectively)]. The combination of the collected fractions (42 × 100 mL) resulted in five main fractions (B/I-V). In fraction B/I (eluted with CH 2 Cl 2 -MeOH 98 : 2), which exhibited marked cell growth-inhibitory effects 
Antiproliferative assay
Antiproliferative effects were measured in vitro on four human cell lines (HeLa, MCF-7, A-431, and MRC-5) by means of the MTT ([3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide]) assay [13] . Briefly, a limited number of human cancer cells (5000/well) were seeded onto a 96-well microplate and became attached to the bottom of the well overnight. On the second day of the procedure, the original medium was removed and 200 µL new medium containing the test substances was added. After an incubation period of 72 h, the living cells were assayed by the addition of 20 µL 5 mg/mL MTT solution. MTT was converted by intact mitochondrial reductase and precipitated as blue formazan crystals during a 4-h contact period. The medium was then removed and the precipitated formazan was dissolved in 100 µL dimethyl sulfoxide (DMSO) during a 60-min period of shaking. Finally, the reduced MTT was assayed at 545 nm by using a microplate reader, wells with untreated cells being taken as the control. All in vitro experiments were carried out on two microplates with at least five parallel wells. Doxorubicin and cisplatin were used as positive controls. Stock solutions of 10 mg/mL of the tested compounds and extracts were prepared with DMSO. The highest DMSO concentration (0.3 %) of the medium did not have any significant effect on the cell proliferation. The dose-response curves of the compounds were fitted by means of the computer program GraphPad Prism 4.0 (GraphPad Software), and IC 50 values were calculated. Doxorubicine and cisplatin were obtained from Ebewe Pharma GmbH as concentrated solutions for intravenous use in human clinical practice. Degree of purity of the tested compounds was determined by HPLC and Table 1 
Results and Discussion
!
The n-hexane and CHCl 3 phases of the methanol extract of the root of C. canadensis, which exerted noteworthy tumour cell growth-inhibitory effects in a preliminary screening experiment, were subjected to multiple chromatographic separations with the guidance of an antiproliferative assay. Thirteen compounds were isolated from the active fractions and tested for their antiproliferative action. Table 1 ). The HSQC and 1 H-1 H COSY experiments on 2 allowed identification of the same scalarly coupled spin systems CH 3 -CH 2 -CH-CH 2 -(A) and -CH=CH-COOCH 3 (B), one isolated methine, and two quaternary carbons. Via the HMBC correlations, the same assignments of the subunits were elucidated. The only significant difference was observed in the coupling constant and 13 C chemical shifts of the disubstituted olefin. The coupling constant value J = 12.4 Hz demonstrated cis geometry of the C-2-C-3 double bond. For 2, NOE effect was detected between H-3 and H-5; accordingly, its structure can be formulated as 2. For this compound too, the presence of two enantiomers (in a ratio of 1 : 1) was indicated by the optical rotation data. The bioactivity-guided chromatographic purification led to the isolation of eleven known compounds, including the C 10 acetylene 4Z,8Z-matricaria-γ-lactone (3), 4E,8Z-matricaria-γ-lactone (4) [14] , the fatty acid 9,12,13-trihydroxy-10(E)-octadecenoic acid (5) [15] , the triterpenes epifriedelanol (6) [16] , friedeline (7) [17], taraxerol (8) [18] , and simiarenol (9) [19] , the sterols spinasterol (10) [20] and a mixture of β-sitosterol and stigmasterol, and the flavone apigenin. Taraxerol (8), simiarenol (9), and 9,12,13-trihydroxy-10(E)-octadecenoic acid (5) are reported for the first time from this plant species. The structures of the compounds were determined by means of ESIMS and 1 H and 13 C NMR spectroscopy, and in some cases with the aid of 1 H-1 H COSY, NOESY, HSQC, and HMBC experiments. The 2D NMR investigations permitted the complete 1 H and 13 C chemical shift assignments for matricaria-γ-lactones 3 and 4, and yielded 13 C NMR data on 9,12,13-trihydroxy-10(E)-octadecenoic acid (5) in CDCl 3 for the first time, as listed in the experimental section. After the isolation of 4Z,8Z-matricaria-γ-lactone (3) and 4E,8Z-matricaria-γ-lactone (4) in pure form, the formation of the isomeric compound was observed in both cases, suggesting an E/Z isomerization process. In contrast with this, it was reported earlier that 4 is produced when 3 is irradiated with UV light, yielding an equilibrium mixture, and 4 was therefore regarded as an artefact [14] . The isolated compounds were evaluated for their inhibitory activities on HeLa, MCF-7, A431, and MRC-5 cells (l " Table 2) , and it was found that different types of secondary metabolites are responsible for the cell growth-inhibitory action of the plant extracts. To different extents, flavone, sterol, triterpene, C 10 acetylene, and dihydropyranone derivatives exhibited concentrationdependent antiproliferative effects. In some cases [4Z,8Z-matricaria-γ-lactone (3) (MCF-7 IC 50 6.90 µM), taraxerol (8) (A431 IC 50 2.65 µM), and apigenin (HeLa IC 50 10.64 µM)], the measured activities were comparable to that of the reference compound cisplatin. Taraxerol (8) , epifriedelanol (6), conyzapyranone A (1), and the mixture of stigmasterol and β-sitosterol displayed the highest activity against A431 cells, while matricaria lactones 3 and 4 demonstrated the highest efficacy against MCF-7 cells, with calculated IC 50 values of 6.90 and 18.74 µM, respectively. Interestingly, friedeline (7), a close analogue of epifriedelanol (6) , was found to be inactive, indicating that the hydroxy group at C-3 is an important structural requirement for the antitumour activity of triterpenes. The antitumour activity of epifriedelanol (6) was demonstrated in vitro in a potato disc bioassay study [16] , but no cytotoxicity was observed against P-388, A-549, MCF-7, HT-29, or KB cells at 10 µg/mL [21] . In our antiproliferative assay, marked activity was detected for apigenin against all three human tumour cell lines, while 9,12,13-trihydroxy-10(E)-octadecenoic acid (5) proved to be inactive. The selective cytotoxic activity of new anticancer drug candidates, natural or synthetic, is one of their most critical pharmacological features. An additional set of MTT assays was therefore performed on noncancerous human foetal lung fibroblast cells (MRC-5) in order to evaluate the selectivity of the currently presented antiproliferative action. Although an ideal anticancer agent is expected not to suppress the proliferation of intact cells, most of the currently used agents, including doxorubicin and cisplatin, are clearly toxic for noncancerous cells. The potency of the two new isolated compounds is not outstanding: conyzapyranone B (2) exhibits substantially lower activity against MRC-5 cells than against malignant cell lines. Similarly, the calculated IC 50 values of epifriedelanol (6), spinasterol (10) , and apigenin indicate more pronounced toxicity on the utilized cancer cells than on MRC-5. In conclusion, this bioactivity-guided phytochemical study of Conyza canadensis resulted in the isolation of two new unusual γ-dihydropyranone derivatives, named conyzapyranone A (1) and B (2), and eleven known compounds, and led to the conclusion that the significant inhibitory effect of the n-hexane and CHCl 3 extracts on the proliferation of cultured human tumour cell lines (HeLa, MCF-7, and A431) may be attributed mainly to flavone, C 10 acetylene, triterpene, and sterol-type compounds. Although 3-hydroxy-γ-pyranone and its derivatives have been reported to be abundant constituents of Conyza species [22] , the structure of conyzapyranones, based on C 10 unsaturated carbon skeleton and having a carboxymethyl functionality, suggests a closer relationship to C 10 acetylenic compounds than to 3-hydroxy-γ-pyranone derivatives. C 10 acetylenes, including diyn-ene (e.g., lachnophyllum ester) or ene-diyn-ene (e.g., matricaria ester) chromophore-containing compounds and C 10 -lactones (e.g., lachnophyllum lactone, matricaria lactone), are typical constituents of the genus Conyza. Incorporation studies have revealed that these compounds are biosynthesized from C 18 acetylenes by multistep β-oxidation or by direct oxidation. It has been supposed that C 10 lactones can be originated from C 10 acetylene acids, and other O- * In µg/mL. "Inactive" indicates that the compound elicited less than 50 % inhibition of cell proliferation at 30 µg/mL, and no higher concentration was tested heterocyclic compounds may also be biosynthetised by a similar way [23] . In case of conyzapyranone A (1) and B (2), the cyclisation of the lachnophyllum methylester [CH 3 CH 2 CH 2 (C≡C) 2 -CH=CH-COOCH 3 ] precursor can be supposed; in this cyclisation the C-4-C-8 part of the molecule may be involved.
